Cost Effectiveness and Resource Allocation

Table 5 The average annual costs of disease conditions in Turkey

From: Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

Disease states	Original costs (TL/year)
Year	2009 (TL)	2014^a (TL)
Compensated cirrhosis	6778	7857
Decompensated cirrhosis	7573	8780
Hepatocellular carcinoma	31,044	35,989

^a2014 costs were calculated by using 3 % reduction ratio according to 2009

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com